Cellab CDMO is a contract development and manufacturing organization specialized in advanced therapies, with a strong focus on cell and gene therapy products. From our facilities in Andorra, we partner with biotechnology companies, hospitals, and research institutions to help translate scientific innovation into therapeutic solutions that can reach patients safely, efficiently, and in compliance with the highest quality standards.

We support our clients throughout the different stages of product development, from preclinical research and process development to GMP manufacturing and preparation for first-in-human clinical trials. Our services include process scale-up, GMP-compliant production, quality control, cryopreservation strategy design, and the development of specific potency assays based on the product’s mechanism of action. In addition, we provide technical and regulatory support for the preparation of key documentation, including the IMPD quality section, to facilitate the transition towards clinical trial authorization.

Our objective is to help bridge the gap between research and clinical application by combining robust scientific development, GMP manufacturing capabilities, regulatory awareness, and a realistic logistics strategy adapted to each therapy.